Header cover image

U.K. (FTSE) Healthtech Industry Analysis

UpdatedNov 28, 2022
DataAggregated Company Financials
Companies11
  • 7D0.8%
  • 3M5.7%
  • 1Y-12.5%
  • YTD-10.3%

In the last week, Healthtech has been flat. Unfortunately though, the industry is down 13% over the past 12 months. Looking forward, earnings are forecast to grow by 22% annually.

Industry Valuation and Performance

Has the U.K. Healthtech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 28 Nov 2022UKĀ£2.3bUKĀ£401.0m-UKĀ£49,811,226.0088.1x-45.6x5.7x
Wed, 26 Oct 2022UKĀ£2.1bUKĀ£407.9m-UKĀ£55,413,217.0070.9x-37.5x5.1x
Fri, 23 Sep 2022UKĀ£2.2bUKĀ£399.4m-UKĀ£55,504,802.0087.7x-40.4x5.6x
Sun, 21 Aug 2022UKĀ£2.2bUKĀ£350.3m-UKĀ£53,785,038.0082.3x-40.2x6.2x
Tue, 19 Jul 2022UKĀ£2.2bUKĀ£347.5m-UKĀ£54,479,453.0076.1x-40.4x6.3x
Thu, 16 Jun 2022UKĀ£1.8bUKĀ£345.7m-UKĀ£48,741,000.0077.2x-37.3x5.3x
Sat, 14 May 2022UKĀ£1.7bUKĀ£344.3m-UKĀ£48,330,497.0076.7x-35.9x5x
Mon, 11 Apr 2022UKĀ£2.1bUKĀ£323.1m-UKĀ£46,946,205.00103.1x-43.8x6.4x
Wed, 09 Mar 2022UKĀ£1.8bUKĀ£286.7m-UKĀ£39,436,568.0068.9x-46.3x6.4x
Fri, 04 Feb 2022UKĀ£2.2bUKĀ£284.4m-UKĀ£38,370,982.0084.7x-57.6x7.8x
Sun, 02 Jan 2022UKĀ£2.7bUKĀ£286.0m-UKĀ£31,157,789.00102.8x-85.5x9.3x
Tue, 30 Nov 2021UKĀ£2.7bUKĀ£282.6m-UKĀ£26,492,965.0099.6x-102.1x9.6x
Thu, 28 Oct 2021UKĀ£2.7bUKĀ£280.9m-UKĀ£25,570,976.0096.3x-107.5x9.8x
Sat, 25 Sep 2021UKĀ£2.8bUKĀ£269.1m-UKĀ£14,752,337.0086.8x-189.9x10.4x
Mon, 23 Aug 2021UKĀ£3.0bUKĀ£266.2m-UKĀ£11,868,606.4867.3x-249.8x11.1x
Sat, 10 Jul 2021UKĀ£2.8bUKĀ£266.2m-UKĀ£11,868,606.4855.5x-234.9x10.5x
Fri, 02 Apr 2021UKĀ£2.5bUKĀ£262.9m-UKĀ£11,200,303.4844.9x-222.1x9.5x
Mon, 04 Jan 2021UKĀ£2.0bUKĀ£259.1m-UKĀ£5,185,482.4044.1x-392.4x7.9x
Thu, 08 Oct 2020UKĀ£1.7bUKĀ£258.8m-UKĀ£3,568,494.7531.1x-464x6.4x
Wed, 01 Jul 2020UKĀ£1.7bUKĀ£258.0m-UKĀ£326,579.9633.2x-5089.8x6.4x
Sat, 04 Apr 2020UKĀ£1.5bUKĀ£256.2mUKĀ£27.8m26.7x53.4x5.8x
Tue, 07 Jan 2020UKĀ£1.8bUKĀ£246.4m-UKĀ£1,569,722.5845.4x-1157.5x7.4x
Price to Earnings Ratio

582.2x


Total Market Cap: UKĀ£1.7bTotal Earnings: UKĀ£3.0mTotal Revenue: UKĀ£247.4mTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Healthtech Industry Price to Earnings3Y Average -360.4x202020212022
Current Industry PE
  • Investors are pessimistic on the British Healthcare Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 8.1x is higher than the industry's current PS ratio of 5.7x.
Past Earnings Growth
  • Total earnings for the Healthcare Services industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 17% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market1.33%
Healthcare0.72%
Healthtech0.76%
Healthtech0.76%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CRW CranewareUKĀ£21.701.9%
+UKĀ£14.0m
-16.2%PE97.9x
RENX RenalytixUKĀ£0.6812.5%
+UKĀ£5.6m
-90.2%PS20.6x
EMIS EMIS GroupUKĀ£18.760.1%
+UKĀ£1.3m
45.9%PE42x
COG Cambridge Cognition HoldingsUKĀ£1.232.1%
+UKĀ£777.2k
-1.6%PE99.8x
IQAI IQ-AIUKĀ£0.0215.0%
+UKĀ£182.6k
-66.4%PS7.1x
Simply Wall Stā„¢
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

RENX

UKĀ£0.68

Renalytix

7D

12.5%

1Y

-90.2%

IUG

UKĀ£0.089

Intelligent Ultrasound Group

7D

-2.7%

1Y

-47.8%

INS

UKĀ£6.70

Instem

7D

-1.8%

1Y

-16.8%

FDBK

UKĀ£0.86

Feedback

7D

-4.9%

1Y

-47.6%

EMIS

UKĀ£18.76

EMIS Group

7D

0.1%

1Y

45.9%

IQAI

UKĀ£0.021

IQ-AI

7D

5.0%

1Y

-66.4%